MUMBAI, Dec 9: Biocon said that it has received its shareholders’ approval to the resolution for transfer of biosimilars business by way of a slump sale to group entity Biocon Biologics India.
The resolution for transfer of Biosimilars business of the company by way of a slump sale as ‘Going Concern’ to Biocon Biologics India has been passed by the members of the company with requisite majority.
The special resolution was passed with 99.99 per cent of votes polled through postal ballot. Biocon is India’s largest leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. (UNI)
Follow our WhatsApp channel